This is the text extract for Provisional agreement with ABM Pharma Limited regarding the listing of various pharmaceuticals on the Pharmaceutical Schedule, browse documents here.

---

16 November 2007 To all Pharmaceutical Suppliers, Hospital Pharmacists, Medical Groups and Interested Parties

Consultation on a provisional agreement with ABM Pharma Limited regarding the listing of various pharmaceuticals on the Pharmaceutical Schedule

The proposal PHARMAC and ABM Pharma have entered into a provisional agreement to list the following pharmaceuticals the Pharmaceutical Schedule: · · · · · · · · · · · Hydroxocobalamin acetate Insulin pen needles Insulin syringes, disposable with attached needle Sunscreen Glycerol Salicylic acid Sodium bicarbonate Sulphur Propylene glycol Methyl hydroxybenzoate Methylcellulose

We are also proposing to amend the restrictions to the listing of sunscreen. PHARMAC is now seeking feedback on this proposal. Details of the proposal Keys aspects of the proposal are as follows: · The following pharmaceuticals would be listed in Section B and in Part II of Section H of the Pharmaceutical Schedule from 1 March 2008 at the following prices and subsidies (ex-manufacturer, excluding GST):

Form Lotion Lotion Liquid Powder Precipitated Liquid Powder Powder Pack Size 100 g OP 200 g OP 2,000 mL 500 g 100 g 500 g 25 g 100 g Brand Marine Blue Lotion SPF 30+ Marine Blue Lotion SPF 30+ ABM ABM ABM ABM ABM ABM Proposed Price and Subsidy $2.55 $5.10 $19.80 $15.00 $6.50 $12.00 $10.00 $14.00

Pharmaceutical Sunscreen Sunscreen Glycerol Salicylic acid Sulphur Propylene glycol Methyl hydroxybenzoate Methylcellulose

A164726 - T07-108

---

·

The following pharmaceuticals would be listed in Section B and in Part II of Section H of the Pharmaceutical Schedule from 1 May 2008 at the following prices and subsidies (ex-manufacturer, excluding GST):

Pharmaceutical Form 29 g x 12.7 mm 31 g x 6 mm 31 g x 8 mm Syringe 0.3 mL with 29 g x 12.7 mm needle Syringe 0.3 mL with 31 g x 8 mm needle Syringe 0.5 mL with 29 g x 12.7 mm needle Syringe 0.5 mL with 31 g x 8 mm needle Syringe 1 mL with 29 g x 12.7 mm needle Syringe 1 mL with 31 g x 8 mm needle Pack Size 100 100 100 100 100 100 100 100 100 Brand ABM ABM ABM ABM ABM ABM ABM ABM ABM Proposed Price and Subsidy $11.75 $11.75 $11.75 $14.45 $14.45 $14.45 $14.45 $14.45 $14.45

Insulin pen needles Insulin pen needles Insulin pen needles Insulin syringes, disposable with attached needle Insulin syringes, disposable with attached needle Insulin syringes, disposable with attached needle Insulin syringes, disposable with attached needle Insulin syringes, disposable with attached needle Insulin syringes, disposable with attached needle

·

The following presentation of sodium bicarbonate powder would be listed in Section B of the Pharmaceutical Schedule from 1 March 2008 and in Part II of Section H of the Pharmaceutical Schedule from 1 July 2008 at the following price and subsidy (exmanufacturer, excluding GST):

Pharmaceutical Form Powder, BP Pack Size 500 g Brand ABM Proposed Price and Subsidy $9.80

Sodium bicarbonate

·

The following presentation of hydroxocobalamin acetate would be listed in Section B and in Part II of Section H of the Pharmaceutical Schedule from 1 June 2008 at the following price and subsidy (ex-manufacturer, excluding GST):

Form Injection Strength 1 mg per mL, 1 mL Pack Size 3 Brand Hydroxocobalamin ABM Proposed Price and Subsidy $9.21

Pharmaceutical Hydroxocobalamin acetate

A164726 - T07-108

---

·

The following products would be referenced priced from 1 July 2008 by reducing their subsidies to the following levels (ex-manufacturer, excluding GST):

Form Cream Cream Lotion Lotion Liquid Powder Powder, BP Powder, BP Precipitated Powder Powder Pack Size 100 g OP 50 g OP 125 ml OP 125 ml OP 2000 mL 500 g 500 g 500 g 100 g 25 g 100 g Brand Hamilton Sunscreen Aquasun Oil Free Faces SPF 30+ Aquasun Sensitive SPF 30+ Aquasun 30+ MidWest David Craig Biomed David Craig PSM PSM MidWest Current subsidy (price) $3.39 ($5.89) $1.74 ($5.53) $4.80 ($8.82) $4.80 ($9.38) $24.75 $29.52 ($55.63) $11.99 $11.99 ($17.50) $7.92 ($9.25) $15.62 (18.45) $17.72 Proposed Subsidy $2.55 $1.28 $3.19 $3.19 $19.80 $15.00 $9.80 $9.80 $6.50 $10.00 $14.00

Pharmaceutical Sunscreen Sunscreen Sunscreen Sunscreen Glycerol Salicylic acid Sodium bicarbonate Sodium bicarbonate Sulphur Methyl hydroxybenzoate Methylcellulose

·

Subsidy and delisting protection for the ABM products would be: o o o until 1 November 2008 for insulin pen needles and insulin syringes, disposable with attached needle; until 1 February 2010 for hydroxocobalamin acetate; and until 1 July 2010 for all other proposed products.

·

Access to subsidised sunscreens would be restricted by the following endorsement criteria from 1 March 2008: “Only if prescribed for a patient with severe photosensitivity secondary to a defined clinical condition.”

· ·

PHARMAC would remove the sunscreens.

“Retail pharmacy-Specialist” restriction from

The listing of ABM Pharma’s brand of insulin pen needle 31 g x 6 mm would not be subject to an age restriction (as is the currently subsidised brand).

A164726 - T07-108

---

How do I make a submission? We are inviting feedback from anyone interested in this proposal. You can make submissions in writing to the addresses that follow. We welcome feedback by email, fax or post. The deadline for submissions is 5pm, Friday, 30 November 2007. By email: By fax: By mail: mike.bignall@pharmac.govt.nz +64 4 460 4995 Mike Bignall PHARMAC PO Box 10-254 Wellington

What will happen then? All of the submissions we receive before the deadline will be taken into consideration before a recommendation is taken to PHARMAC’s Board, or Acting Chief Executive under delegated authority. Submissions will also be provided to the decision maker when considering the recommendation. The PHARMAC Board, or Acting Chief Executive under delegated authority, will then make a decision on this proposal. If a decision to accept this proposal is made, it is anticipated that the proposed changes would take effect from 1 March 2008 at the earliest. Where can I find more information? You can seek further information by calling Mike Bignall on +64 4 916 7562 or by e-mail mike.bignall@pharmac.govt.nz. We look forward to receiving your feedback on this proposal. Yours sincerely

Mike Bignall Therapeutic Group Manager

A164726 - T07-108